Phase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS Vaccines
Clinical trial NCT05925127 · COMPLETED
Trial details
- NCT number
- NCT05925127
- Sponsor
- Novavax
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-16
- Primary completion
- 2024-05-21
- Enrollment
- 994
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.